...
gbio-img

Generation Bio Co, Common Stock

GBIO

NSQ

$1.02

-$0.07

(-6.42%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$72.80M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
2.92M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
2.82
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.75 L
$4.65 H
$1.02

About Generation Bio Co, Common Stock

Generation Bio Co. develops non-viral genetic medicines for the treatment of rare and prevalent diseases. The company develops cell-targeted lipid nanoparticle (ctLNP) platform, a modular delivery system for nucleic acids to avoid off-target clearance by the liver and spleen that enables ctLNPs to persist in systemic circulation, which allows for highly selective and potent ligand-driven targeting to specific tissues and cell types; and novel immune-quiet DNA (iqDNA) to enable long-lasting high levels of gene expression from non-integrating episomes and avoids innate immune sensors that have long prevented DNA from use in non-viral systems. It uses its platform for developing a portfolio of programs for treating cancer, autoimmune, hematologic disorders, prioritizing sickle cell, beta-thalassemia, and hemophilia A diseases, as well as for other tissues and cell types, including retina, skeletal muscle, and central nervous system. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameGBIOSectorS&P500
1-Week Return-19.69%-2.06%-0.55%
1-Month Return-28.67%-1.92%2.72%
3-Month Return-60.62%-10.4%7.66%
6-Month Return-62.22%-4.6%10.15%
1-Year Return-46.6%4.06%27.53%
3-Year Return-86.4%1.94%32.31%
5-Year Return-95.87%36.48%89.2%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue---880.00K5.90M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":14.91,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue1.86M3.43M4.53M5.13M79.81M[{"date":"2019-12-31","value":2.34,"profit":true},{"date":"2020-12-31","value":4.3,"profit":true},{"date":"2021-12-31","value":5.68,"profit":true},{"date":"2022-12-31","value":6.43,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit(1.86M)(3.43M)(4.53M)(5.13M)(73.91M)[{"date":"2019-12-31","value":-186400000,"profit":false},{"date":"2020-12-31","value":-343200000,"profit":false},{"date":"2021-12-31","value":-453200000,"profit":false},{"date":"2022-12-31","value":-513000000,"profit":false},{"date":"2023-12-31","value":-7391100000,"profit":false}]
Gross Margin---(582.95%)(1251.88%)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-582.95,"profit":false},{"date":"2023-12-31","value":-1251.88,"profit":false}]
Operating Expenses62.30M81.11M119.10M141.18M144.47M[{"date":"2019-12-31","value":43.13,"profit":true},{"date":"2020-12-31","value":56.15,"profit":true},{"date":"2021-12-31","value":82.44,"profit":true},{"date":"2022-12-31","value":97.73,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(62.30M)(81.11M)(119.10M)(141.18M)(138.56M)[{"date":"2019-12-31","value":-6230200000,"profit":false},{"date":"2020-12-31","value":-8111400000,"profit":false},{"date":"2021-12-31","value":-11910100000,"profit":false},{"date":"2022-12-31","value":-14118200000,"profit":false},{"date":"2023-12-31","value":-13856300000,"profit":false}]
Total Non-Operating Income/Expense1.97M1.18M(100.00K)9.09M23.90M[{"date":"2019-12-31","value":8.24,"profit":true},{"date":"2020-12-31","value":4.95,"profit":true},{"date":"2021-12-31","value":-0.42,"profit":false},{"date":"2022-12-31","value":38.01,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(61.32M)(80.52M)(119.15M)(136.64M)(126.61M)[{"date":"2019-12-31","value":-6131700000,"profit":false},{"date":"2020-12-31","value":-8052300000,"profit":false},{"date":"2021-12-31","value":-11915100000,"profit":false},{"date":"2022-12-31","value":-13663900000,"profit":false},{"date":"2023-12-31","value":-12661200000,"profit":false}]
Income Taxes(985.00K)(4.02M)(4.48M)(4.54M)5.10M[{"date":"2019-12-31","value":-19.33,"profit":false},{"date":"2020-12-31","value":-78.96,"profit":false},{"date":"2021-12-31","value":-87.97,"profit":false},{"date":"2022-12-31","value":-89.16,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(60.33M)(76.50M)(114.67M)(132.10M)(131.71M)[{"date":"2019-12-31","value":-6033200000,"profit":false},{"date":"2020-12-31","value":-7650000000,"profit":false},{"date":"2021-12-31","value":-11466900000,"profit":false},{"date":"2022-12-31","value":-13209600000,"profit":false},{"date":"2023-12-31","value":-13170710500,"profit":false}]
Income From Continuous Operations(61.32M)(80.52M)(119.15M)(136.64M)(126.61M)[{"date":"2019-12-31","value":-6131700000,"profit":false},{"date":"2020-12-31","value":-8052300000,"profit":false},{"date":"2021-12-31","value":-11915100000,"profit":false},{"date":"2022-12-31","value":-13663900000,"profit":false},{"date":"2023-12-31","value":-12661200000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(60.33M)(76.50M)(114.67M)(132.10M)(126.61M)[{"date":"2019-12-31","value":-6033200000,"profit":false},{"date":"2020-12-31","value":-7650000000,"profit":false},{"date":"2021-12-31","value":-11466900000,"profit":false},{"date":"2022-12-31","value":-13209600000,"profit":false},{"date":"2023-12-31","value":-12661200000,"profit":false}]
EPS (Diluted)-(3.29)(2.11)(2.35)(1.96)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-329,"profit":false},{"date":"2021-12-31","value":-211,"profit":false},{"date":"2022-12-31","value":-235,"profit":false},{"date":"2023-12-31","value":-196,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

GBIO
Cash Ratio 6.13
Current Ratio 6.34

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

GBIO
ROA (LTM) -19.29%
ROE (LTM) -86.50%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

GBIO
Debt Ratio Lower is generally better. Negative is bad. 0.58
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.42

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

GBIO
Trailing PE NM
Forward PE NM
P/S (TTM) 3.92
P/B 0.74
Price/FCF NM
EV/R 5.10
EV/Ebitda NM

FAQs

What is Generation Bio Co share price today?

Generation Bio Co (GBIO) share price today is $1.02

Can Indians buy Generation Bio Co shares?

Yes, Indians can buy shares of Generation Bio Co (GBIO) on Vested. To buy Generation Bio Co from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in GBIO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Generation Bio Co be purchased?

Yes, you can purchase fractional shares of Generation Bio Co (GBIO) via the Vested app. You can start investing in Generation Bio Co (GBIO) with a minimum investment of $1.

How to invest in Generation Bio Co shares from India?

You can invest in shares of Generation Bio Co (GBIO) via Vested in three simple steps:

  • Click on Sign Up or Invest in GBIO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Generation Bio Co shares
What is Generation Bio Co 52-week high and low stock price?

The 52-week high price of Generation Bio Co (GBIO) is $4.65. The 52-week low price of Generation Bio Co (GBIO) is $0.75.

What is Generation Bio Co price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Generation Bio Co (GBIO) is

What is Generation Bio Co price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Generation Bio Co (GBIO) is 0.74

What is Generation Bio Co dividend yield?

The dividend yield of Generation Bio Co (GBIO) is 0.00%

What is the Market Cap of Generation Bio Co?

The market capitalization of Generation Bio Co (GBIO) is $72.80M

What is Generation Bio Co’s stock symbol?

The stock symbol (or ticker) of Generation Bio Co is GBIO

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top